Ministry of Science and Technology by the Center of Excellence in Life Sciences (Public Organization) or TCELS, Pharmaceutical and Cell Therapy Management Program Department Join forces with Cryoviva (Thailand) Company Limited to organize a cooperation contract signing ceremony. "Establishing a testing laboratory and quality control of cell and gene therapy products" on January 10, 2019 at the conference room, 20th floor, Center of Excellence in Life Sciences. (Public Organization) by Dr. Nares Damrongchai, Director of the Life Science Center of Excellence, and Ms. Jiranya Pracharaseree, Chief Executive Officer of Cryoviva (Thailand) Company Limited, signed a cooperation agreement.
Establishing a testing laboratory and quality control of cell and gene therapy products" with Dr. Sirasak Thepakam, Deputy Director of the Center of Excellence for Life Sciences, and Ms. Kamonrat Srithawin, Chief Operating Officer of Cryoviva (Thailand) Company Email Marketing List Limited, joining as martyrs. Witness to the signing, Dr. Nares Damrongchai, revealed that “the signing of this memorandum of understanding To develop the organization to have a standardized organizational management system. Increase work efficiency to be fast, accurate, accurate, transparent, verifiable, and integrate information from all departments within the organization together.
The system is used on the same database. which is in line with the policy for developing government organizations towards Thailand 4.0" "for testing laboratories and control the quality of cell and gene therapy products It is under the operation of the Cell and Gene Therapy Product Production Unit, located at Innovation Group Building 2, Building C, 2nd floor, Thailand Science Park, Pathum Thani Province. The establishment of this project To provide quality assurance services and quality assurance To protect the safety of users of cell and gene therapy products at international standards. Including operating in accordance with the Drug Act.
Establishing a testing laboratory and quality control of cell and gene therapy products" with Dr. Sirasak Thepakam, Deputy Director of the Center of Excellence for Life Sciences, and Ms. Kamonrat Srithawin, Chief Operating Officer of Cryoviva (Thailand) Company Email Marketing List Limited, joining as martyrs. Witness to the signing, Dr. Nares Damrongchai, revealed that “the signing of this memorandum of understanding To develop the organization to have a standardized organizational management system. Increase work efficiency to be fast, accurate, accurate, transparent, verifiable, and integrate information from all departments within the organization together.
The system is used on the same database. which is in line with the policy for developing government organizations towards Thailand 4.0" "for testing laboratories and control the quality of cell and gene therapy products It is under the operation of the Cell and Gene Therapy Product Production Unit, located at Innovation Group Building 2, Building C, 2nd floor, Thailand Science Park, Pathum Thani Province. The establishment of this project To provide quality assurance services and quality assurance To protect the safety of users of cell and gene therapy products at international standards. Including operating in accordance with the Drug Act.
